News

Fovista, an aptamer directed against platelet-derived growth factor subunit B (PDGF-B), regulates the cells associated with the walls of newly formed small blood vessels, the neovascular pericytes. The

The vaccine combined Immunovaccine’s DepoVax adjuvanting technology and Weill Cornell’s novel anti-cocaine vaccine (dAd5GNE). Immunovaccine chief science officer Dr. Marc Mansour said the company’s delivery system holds the

Under the agreement, AnGes will receive upfront payments, performance based milestone payments and payments after the product launch in accordance with its sales. AnGes president and CEO Ei

Pursuant to the three-year indefinite delivery/indefinite quantity contract, Cellectis will provide services such as generation of induced pluripotent stem (iPS) cell lines of research grade and differentiation of

Scilligence’s informatics products usage will enhance knowledge sharing and productivity of researchers in the discovery and development of small molecule and biologics therapeutics. In addition, Scilligence’s proprietary technology

The PK study assessed a single dose of one 2.4mg tablet or two tablets (4.8mg) of TNX-102 SL or the presently-marketed 5mg CBP tablet. The data revealed that

Xalkori blocks signaling in a number of cell pathways supposed to be important for the growth and survival of tumor cells, by inhibiting the ALK fusion protein. With

Using Pincer platform, Mediomics will develop antigen-specific assays for antibody titer, affinity, glycosylation and aggregation and is also expected to culminate with beta-testing by Gallus Biopharmaceuticals. The company

According to the study data, the oral administration of laquinimod 0.5mg/day exhibitted the steady effect on remission and response rates in patients with moderate-to-severe CD versus placebo. Teva